Saelens; Xavier

Patent Applications and Registrations

Patent applications and USPTO patent grants for Saelens; Xavier.The latest application filed is for "mixed-lineage kinase domain-like protein in immunotherapeutic cancer control".

Company Profile

6.11.15

Saelens; Xavier - Ypres BE
Saelens; Xavier - Ieper BE
Saelens; Xavier - leper BE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Immunoglobulin single variable domain antibody against RSV prefusion F protein Grant 11,248,039 - Saelens , et al. February 15, 2	2022-02-15
Mixed-lineage Kinase Domain-like Protein In Immunotherapeutic Cancer Control App 20210121522 - Saelens; Xavier ; et al.	2021-04-29
Respiratory Syncytial Virus Vaccine App 20210106673 - Saelens; Xavier ; et al.	2021-04-15
Methods Of Generating Broadly Protective Vaccine Compositions Comprising Neuraminidase App 20210046176 - Strugnell; Tod ; et al.	2021-02-18
Immunoglobulin Single Variable Domain Antibody Against Rsv Prefusion F Protein App 20200102374 - SAELENS; Xavier ; et al.	2020-04-02
Immunoglobulin single variable domain antibody against RSV prefusion F protein Grant 10,501,528 - Saelens , et al. Dec	2019-12-10
Respiratory Syncytial Virus Vaccine App 20190083605 - Saelens; Xavier ; et al.	2019-03-21
Respiratory syncytial virus vaccine Grant 10,117,926 - Saelens , et al. November 6, 2	2018-11-06
Anti-influenza antibody Grant 10,023,629 - Saelens , et al. July 17, 2	2018-07-17
Immunoglobulin Single Variable Domain Antibody Against Rsv Prefusion F Protein App 20180179266 - SAELENS; Xavier ; et al.	2018-06-28
Pulmonary administration of immunoglobulin single variable domains and constructs thereof Grant 9,725,522 - Bouche , et al. August 8, 2	2017-08-08
Anti-influenza Antibody App 20160376347 - Saelens; Xavier ; et al.	2016-12-29
Respiratory Syncytial Virus Vaccine App 20160346379 - Saelens; Xavier ; et al.	2016-12-01
Antibody constructs for influenza M2 and CD3 Grant 9,505,849 - Kufer , et al. November 29, 2	2016-11-29
Pulmonary Administration Of Immunoglobulin Single Variable Domains And Constructs Thereof App 20160280799 - BOUCHE; MARIE-PAULE LUCIENNE ARMANDA ; et al.	2016-09-29
Respiratory syncytial virus vaccine Grant 9,409,973 - Saelens , et al. August 9, 2	2016-08-09
Pulmonary administration of immunoglobulin single variable domains and constructs thereof Grant 9,320,792 - Bouche , et al. April 26, 2	2016-04-26
Antibody Constructs For Influenza M2 And Cd3 App 20160039948 - Kufer; Peter ; et al.	2016-02-11
Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases Grant 9,193,780 - Hultberg , et al. November 24, 2	2015-11-24
Respiratory Syncytial Virus Vaccine App 20130315916 - Saelens; Xavier ; et al.	2013-11-28
Pulmonary Administration Of Immunoglobulin Single Variable Domains And Constructs Thereof App 20130136744 - Bouche; Marie-Paule Lucienne Armanda ; et al.	2013-05-30
Pulmonary Administration Of Immunoglobulin Single Variable Domains And Constructs Thereof App 20110311515 - Bouche; Marie-Paule Lucienne Armanda ; et al.	2011-12-22
Amino Acid Sequences Directed Against Envelope Proteins Of A Virus And Polypeptides Comprising The Same For The Treatment Of Viral Diseases App 20110182897 - Hultberg; Anna ; et al.	2011-07-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.